Back to Search
FRANTZ LEREBOURS, M.D.
M.D.
Ophthalmology Physician
NPI: 1780606970IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
154863(NY)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
OTHER
Class of 1978
Research & Publications (19)
18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
PMID 19645022·Cancer·2009
3-trial
Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.
PMID 19204198·J Clin Oncol·2009
8-other
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.
PMID 19118060·Clin Cancer Res·2009
3-trial
NF-kappa B genes have a major role in inflammatory breast cancer.
PMID 18248671·BMC Cancer·2008
8-other
[Primary systemic therapy in breast cancer: clinical and molecular factors predictors of outcome and response].
PMID 16753495·Pathol Biol (Paris)·2006
6-review
Prognostic significance of a combined clinicopathologic score for response to primary systemic therapy in locally advanced breast cancer.
PMID 16012739·Oncol Rep·2005
8-other
Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.
PMID 15501955·Clin Cancer Res·2004
8-other
Two prognostic groups of inflammatory breast cancer have distinct genotypes.
PMID 14519644·Clin Cancer Res·2003
8-other
Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
PMID 12684393·Clin Cancer Res·2003
8-other
Real-time reverse transcription PCR assay of CYP19 expression: application to a well-defined series of post-menopausal breast carcinomas.
PMID 12589939·J Steroid Biochem Mol Biol·2002
4-observational
Evidence of chromosome regions and gene involvement in inflammatory breast cancer.
PMID 12448004·Int J Cancer·2002
8-other
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.
PMID 12386822·Oncogene·2002
8-other
Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy.
PMID 12243922·Lancet·2002
8-other
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study.
PMID 11720455·Br J Cancer·2001
3-trial
ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinoma.
PMID 11689293·Cancer Lett·2001
8-other
Allelic loss detection in inflammatory breast cancer: improvement with laser microdissection.
PMID 11598152·Lab Invest·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 22812 LINDEN BLVD
CAMBRIA HEIGHTS, NY 11411 - Phone
- (718) 528-3206
Quick Facts
- NPI
- 1780606970
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 19
Are you this provider?
Claim Your Profile